A Phase I, Single Centre, Double-Blind, Randomised, Placebo- Controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Inhaled Doses of AZD8683 in Healthy Volunteers and COPD Patients
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2012
At a glance
- Drugs AZD 8683 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 01 Nov 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 22 Jun 2012 Actual initiation date (Jun 2012) added as reported by ClinicalTrials.gov.